Navigation Links
Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
Date:1/24/2012

#160; 

 

Net income

-

5.9

5.9

 

 

 

  

 

Diluted earnings per common share

-

0.03

0.03

 

 

 

  

4)

The following table summarizes the impact to the year over year comparisons for the Medi-Cal charge, transaction costs, restructuring and integration charges, CEO succession costs, the estimated impact of severe weather and the employment litigation settlement on certain reported results for the twelve months ended December 31, 2011 and 2010 (in millions, except per share data):  

 

 

 

Twelve Months Ended December 31, 2011 and 2010 

 

 

 

Medi-Cal Charge 

 

Transaction Costs 

 

 

 

2011 

2010Better(Worse) 

 

2011 

2010Better(Worse) 

 

 

 

 

 

 

 

 

  

 

Cost of services

$
-

$
-

$
-

 

$
-

$
-

$

 

Selling, general and administrative

-

-

-

 

16.9

-

(16.9) 

 

Operating income

236.0

-

(236.0)

 

16.9

-

(16.9) 

 

Net income

194.7

-

(194.7)

 

15.2

-

(15.2) 

 

Diluted earnings per common share

1.22

-


'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. NIH Funds $1M Research at Quest Product Development and University of Colorado for New Digitally-Controlled Endoscopes
2. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
3. Latest Sleep Disorder Technology Tested With SleepQuest
4. PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
5. NeurogesX Responds to EMEAs Day 120 Questions
6. Nasdaq Grants VirtualScopics Request for Continued Listing
7. Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter
8. SleepQuest Tireless in Pursuit of Good Sleep
9. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
10. Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox
11. SciQuest Announces Strategic Alliance with QIAGEN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Wellesley, Mass. (PRWEB) , ... September 02, 2015 ... ... that includes development of botanical and plant-derived compounds. BCC Research reveals in ... drugs past 2020 because this market defines the category and generates the most ...
(Date:9/2/2015)... Calif. , Sept. 2, 2015 Veracyte, ... Bonnie H. Anderson , president and chief executive officer, ... on Wednesday, September 16, 2015 at 10:30 a.m. ET ... The live audio webcast and subsequent replay ... The webcast will be available shortly after conclusion of ...
(Date:9/2/2015)... ... September 02, 2015 , ... Advancing ... high-risk surgeries. From vital sign monitoring in ICU to 3D skull printing analysis ... to make real-time clinical decisions with simultaneous access to high precision medical images ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... and life science research, today unveiled Genedata Screener ® version 13.0 at ... in-vitro screening brings to market a rich set of new capabilities. Screener now ...
Breaking Biology Technology:Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4
... Replidyne, Inc.,(Nasdaq: RDYN ) today announced its financial ... 2008., Replidyne reported a net loss of $18.7 million ... per basic and diluted common share of $0.69,per share, compared ... share or $1.65 per common share on a fully diluted ...
... Nexavar Net Sales increase 107% over Second Quarter 2007, ... ONXX ) today reported its financial results,for the ... reported net income,of $4.5 million, or $0.08 per diluted ... net loss of $10.8 million, or $0.22 per diluted ...
... Aug. 5 TriMix Laboratories LLC today,announced it ... Solutions,as the exclusive pharmacy for prescription fulfillment of ... as a first line and secondary,treatment for erectile ... compounding pharmacy which makes TriMix gel(TM) medicine for,each ...
Cached Biology Technology:Replidyne Announces Second Quarter 2008 Results From Operations 2Replidyne Announces Second Quarter 2008 Results From Operations 3Replidyne Announces Second Quarter 2008 Results From Operations 4Replidyne Announces Second Quarter 2008 Results From Operations 5Replidyne Announces Second Quarter 2008 Results From Operations 6Replidyne Announces Second Quarter 2008 Results From Operations 7Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 2Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 3Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 4Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 5Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 6Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 7Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 8Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 9Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results 10TriMix Laboratories Announces New Partnership With American Pharmacy Solutions 2TriMix Laboratories Announces New Partnership With American Pharmacy Solutions 3
(Date:8/5/2015)... Aug. 5, 2015 The biosensors market is ... applications, penetration into newer sectors, and development of devices ... biosensors space has seen the entry of multiple participants ... far. (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... Analysis of the Global Biosensors Market ( http://www.frost.com/nee9 ...
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... 2015 Den 10. internationale konference om Genomik ... 22. - 25. oktober i Shenzhen ... fødselsdag i år. Siden starten i 2006 er ICB ... ,omik,-feltet, og er en af de mest dynamiske, entusiastiske ... på nylige gennembrud og fremskridt inden for ,omik,-forskning, som ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
... Überwachung drinnen und im Freien ... Solutions (WTS), ein technologisches Startup-Unternehmen aus Schweden, stellt ... Ein intelligentes, neues Gerät mit dazugehöriger App, das ... immer und von überall aus zu lokalisieren. Trax ...
... the Advancement of Science has announced that the Johns ... the Department of Biophysics and Biophysical Chemistry; Philip Cole, ... Sciences; Valina Dawson, Ph.D., of the Department of Neurology; ... the Henry A. Rowland Department of Physics and Astronomy ...
... Boulder, Colo., USA GSA Bulletin articles posted online ... Sinai-Negev erg of Egypt and Israel; petrology in the ... in the Central Andes of Argentina; sedimentology of the ... Tepetiltic, western Mexico; and thermochronology of the Appalachian Mountains. ...
Cached Biology News:Halten Sie Ihre Kinder und Haustiere mit TRAX im Auge - dem neuen, intelligenten GPS-Tracker 2Halten Sie Ihre Kinder und Haustiere mit TRAX im Auge - dem neuen, intelligenten GPS-Tracker 34 Johns Hopkins researchers named AAAS Fellows 2GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 2GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 3GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 4GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 5GSA Bulletin posts new studies from China, Egypt and Israel, Argentina, Mexico, California, Appalachia 6
Non-Protein Peroxidase Stabilizer , 1 L...
Component of GELase™ Agarose Gel-Digesting Preparation. 1 ml of 50X Buffer is sufficient for replacing the buffer in at least 5 g of gel....
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Request Info...
Biology Products: